Bio-Rad Laboratories Stock Price (NYSE:BIO)

Add to My Stocks
$192.06 $1.21 (0.63%) BIO stock closing price Feb 21, 2017 (Closing)
YOUR DAILY UPDATE ON
BIO
Bio-Rad Laboratories
21 FEB 2017
amigobulls logo
BIO hand_up
BIO vs S&P 500
Closing Price: Feb 21, 2017
BIO
$192.06 ( -0.63%)
S&P 500
2365.4 ( 0.6%)
BIO
52 Week Price Range
1 Year Return: 46.05%
Q3 Growth*
On Par
Profitable ?
Yes
net image
2016 Q3 Net Profit
4.7%
PE Valuation
Expensive*
home image
Rating
BIO AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Bio-Rad Laboratories Snapshot Video

11 5 2

BIO Stock Details

Prev Close* : $193.27
Market Cap:
$5.71B
Day Low: $191.3
52 Week Low: $129.07
Open: $193.27
Volume: 148420
Day High: $194.25
52 Week High: $194.20
Dividend:
N/A

Latest Stock Market News

Latest Articles

Bio-Rad Laboratories News - From Partners

BIO Stockcharts

View BIO PE ratio, PS ratio stocks charts and compare with peers.
BIO Chart
Note: Compare Bio-Rad Laboratories stock price history with the index and industry peers.

Bio-Rad Laboratories Valuation

PE ratio
(price earnings ratio)
57.68
PS ratio (
price to sales ratio
)
2.74
PB ratio (
price to book ratio
)
2.21

Bio-Rad Laboratories Returns

ROE
(return on equity)
4%

Bio-Rad Laboratories Financial Ratios

Asset Turnover
0.52
Receivables Turnover
5.59
Debt to Equity
0.16

BIO Industry Peers

Company Price Change (%)
Lonza Group (LZAGY)17.90.04 (0.22%)
Resmed (RMD)72.210.06 (0.08%)
Thermo Fisher Scientific (TMO)158.630.01 (0.01%)
Harvard Bioscience (HBIO)3.050.05 (1.61%)
Danaher (DHR)84.750.7 (0.83%)
Affymetrix (AFFX)14.010.02 (0.14%)
General Electric (GE)30.520.15 (0.49%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Insys Therapeutics (INSY)12.651.55 (13.96%)
Omeros (OMER)11.460.44 (3.99%)
LeMaitre Vascular (LMAT)24.590.79 (3.32%)
Owens & Minor (OMI)35.961.06 (3.04%)
Invivo Therapeautics (NVIV)4.550.1 (2.25%)
Medtronic (MDT)80.561.68 (2.13%)
SurModics (SRDX)25.20.4 (1.61%)
Top gainers from Medical Products industry
* As of Feb 21, 2017
CompanyPriceChange (%)
Agios Pharma (AGIO)50.43.69 (6.82%)
Chimerix (CMRX)5.680.27 (4.54%)
MacroGenics (MGNX)20.520.87 (4.07%)
Cerus (CERS)4.140.15 (3.5%)
Cardiovascular Systems (CSII)28.171.02 (3.49%)
Conatus Pharma (CNAT)5.070.18 (3.43%)
Rockwell Medical (RMTI)5.830.17 (2.83%)
Top losers from Medical Products industry
* As of Feb 21, 2017

Bio-Rad Laboratories Financial Statements

income statement20152014201320122011
Net Sales Or Revenues2.02B2.18B2.13B2.07B2.07B
Net Income113.09M88.84M77.78M163.77M178.22M
Total Operating Expense954.96M1.03B1.01B896.93M882.72M
view Bio-Rad Laboratories, Inc. income statement
balance sheet20152014201320122011
Total Assets3.71B3.34B3.39B3.44B3.1B
Total Liabilities1.22B1.16B1.2B1.43B1.35B
Shareholders Equity2.49B2.19B2.19B2.01B1.74B
view Bio-Rad Laboratories, Inc. balance sheet

Bio-Rad Laboratories, Inc. Stock News - Partner Headlines

Bio-Rad Laboratories Stock Message Board

As of last trading day, Bio-Rad Laboratories stock price was 193.27. Bio-Rad Laboratories market capitalization is 5.71B and it represents the total market value of BIO stock. Bio-Rad Laboratories valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Bio-Rad Laboratories is worth a lot, it will most likely be reflected in an inflated Bio-Rad Laboratories stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 113452 on the last trading day, as is evident from Bio-Rad Laboratories stock chart, and BIO stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. One can observe stock price trends and check for volatility by checking Bio-Rad Laboratories stock price history.